Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia: target attainment requires further increase of intensity

Familial hypercholesterolemia (FH) causes premature cardiovascular disease (CVD). Lipoprotein apheresis (LA) is recommended as first-line lipid-lowering treatment (LLT) for homozygous (ho) FH.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Klaus, Günter (VerfasserIn) , Schmitt, Claus P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 3 March 2018
In: Pediatric nephrology
Year: 2018, Jahrgang: 33, Heft: 7, Pages: 1199-1208
ISSN:1432-198X
DOI:10.1007/s00467-018-3906-6
Online-Zugang:Resolving-System, Volltext: https://doi.org/10.1007/s00467-018-3906-6
Verlag: https://link.springer.com/article/10.1007%2Fs00467-018-3906-6
Volltext
Verfasserangaben:Günter Klaus, Christina Taylan, Rainer Büscher, Claus Peter Schmitt, Lars Pape, Jun Oh, Joenna Driemeyer, Matthias Galiano, Jens König, Carsten Schürfeld, Ralf Spitthöver, Juergen R. Schaefer, Lutz T. Weber, Andreas Heibges, Reinhard Klingel

MARC

LEADER 00000caa a2200000 c 4500
001 1680053337
003 DE-627
005 20230426084706.0
007 cr uuu---uuuuu
008 191028s2018 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00467-018-3906-6  |2 doi 
035 |a (DE-627)1680053337 
035 |a (DE-599)KXP1680053337 
035 |a (OCoLC)1341249423 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Klaus, Günter  |e VerfasserIn  |0 (DE-588)1106410408  |0 (DE-627)863131182  |0 (DE-576)474097021  |4 aut 
245 1 0 |a Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia  |b target attainment requires further increase of intensity  |c Günter Klaus, Christina Taylan, Rainer Büscher, Claus Peter Schmitt, Lars Pape, Jun Oh, Joenna Driemeyer, Matthias Galiano, Jens König, Carsten Schürfeld, Ralf Spitthöver, Juergen R. Schaefer, Lutz T. Weber, Andreas Heibges, Reinhard Klingel 
264 1 |c 3 March 2018 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.10.2019 
520 |a Familial hypercholesterolemia (FH) causes premature cardiovascular disease (CVD). Lipoprotein apheresis (LA) is recommended as first-line lipid-lowering treatment (LLT) for homozygous (ho) FH. 
650 4 |a Children 
650 4 |a Familial hypercholesterolemia 
650 4 |a LDL-cholesterol 
650 4 |a Lipoprotein apheresis prevention 
650 4 |a Treatment 
700 1 |a Schmitt, Claus P.  |e VerfasserIn  |0 (DE-588)1030179123  |0 (DE-627)734893620  |0 (DE-576)377990280  |4 aut 
773 0 8 |i Enthalten in  |t Pediatric nephrology  |d Berlin : Springer, 1987  |g 33(2018), 7, Seite 1199-1208  |h Online-Ressource  |w (DE-627)254638872  |w (DE-600)1463004-7  |w (DE-576)074531689  |x 1432-198X  |7 nnas  |a Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia target attainment requires further increase of intensity 
773 1 8 |g volume:33  |g year:2018  |g number:7  |g pages:1199-1208  |g extent:10  |a Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia target attainment requires further increase of intensity 
856 4 0 |u https://doi.org/10.1007/s00467-018-3906-6  |x Resolving-System  |x Verlag  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007%2Fs00467-018-3906-6  |x Verlag 
951 |a AR 
992 |a 20191028 
993 |a Article 
994 |a 2018 
998 |g 1030179123  |a Schmitt, Claus P.  |m 1030179123:Schmitt, Claus P.  |d 910000  |d 910500  |e 910000PS1030179123  |e 910500PS1030179123  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 1106410408  |a Klaus, Günter  |m 1106410408:Klaus, Günter  |d 50000  |e 50000PK1106410408  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1680053337  |e 3529235830 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Günter Klaus, Christina Taylan, Rainer Büscher, Claus Peter Schmitt, Lars Pape, Jun Oh, Joenna Driemeyer, Matthias Galiano, Jens König, Carsten Schürfeld, Ralf Spitthöver, Juergen R. Schaefer, Lutz T. Weber, Andreas Heibges, Reinhard Klingel"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"3 March 2018"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1680053337","id":{"doi":["10.1007/s00467-018-3906-6"],"eki":["1680053337"]},"person":[{"role":"aut","family":"Klaus","display":"Klaus, Günter","given":"Günter"},{"given":"Claus P.","display":"Schmitt, Claus P.","family":"Schmitt","role":"aut"}],"language":["eng"],"note":["Gesehen am 28.10.2019"],"title":[{"title":"Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia","title_sort":"Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia","subtitle":"target attainment requires further increase of intensity"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"254638872","id":{"eki":["254638872"],"zdb":["1463004-7"],"issn":["1432-198X"]},"origin":[{"publisher":"Springer ; Springer","dateIssuedDisp":"1987-","dateIssuedKey":"1987","publisherPlace":"Berlin ; Heidelberg ; Berlin ; Heidelberg ; New York, NY"}],"disp":"Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia target attainment requires further increase of intensityPediatric nephrology","language":["eng"],"pubHistory":["1.1987 -"],"note":["Gesehen am 06.12.05"],"part":{"volume":"33","text":"33(2018), 7, Seite 1199-1208","issue":"7","year":"2018","pages":"1199-1208","extent":"10"},"title":[{"title":"Pediatric nephrology","title_sort":"Pediatric nephrology","subtitle":"journal of the International Pediatric Nephrology Association"}],"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a KLAUSGUENTMULTIMODAL3201